MEITAV INVESTMENT HOUSE LTD - NEUROSENSE THERAPEUTICS LTD ownership

NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of NEUROSENSE THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$67,450
-76.2%
95,000
-50.0%
0.00%
-50.0%
Q2 2023$283,100
+46.5%
190,000
+100.0%
0.00%
-33.3%
Q1 2023$193,28095,0000.00%
Other shareholders
NEUROSENSE THERAPEUTICS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Vanguard Personalized Indexing Management, LLC 39,634$134,0000.01%
CLEAR STREET LLC 7,157$24,0000.00%
Tower Research Capital LLC (TRC) 9,794$33,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 20,259$68,0000.00%
CITIGROUP INC 49,744$168,0000.00%
JANE STREET GROUP, LLC 77,249$261,0000.00%
UBS Group AG 13,428$45,0000.00%
View complete list of NEUROSENSE THERAPEUTICS LTD shareholders